NewsRx

Search our medical news database

Angiography

Novadaq announces CE Mark for OPTTX System

Published in Health Business Week, December 8th, 2006

Novadaq Technologies Inc. (NDQ) has received the necessary CE Mark Certificates from their Notified Body to market the OPTTX System in Europe.

The OPTTX System is the only commercially available medical device that allows for diagnosis, treatment and ongoing management of wet age-related macular degeneration (AMD) patients, all in a single device.

The OPTTX System produces ultra high-speed indocyanine green (ICG) angiograms and facilitates the identification of choroidal feeder vessels (FVs). In addition, the OPTTX System allows for viewing a real-time angiogram in which the treatment laser is able to track and fire precisely while the FV is visible....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook